Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine that a new drug called "Rivaroxaban®" is effective
in preventing patients from forming clots after their heart rhythm has been reset by the
cardiologist with an electrical device.